海翔药业：累计回购441万股

Group 1 - Company HaiXiang Pharmaceutical announced a share buyback of 4.41 million shares, representing 0.27% of its total share capital, with a total transaction amount of approximately 26.09 million RMB [1] - The highest transaction price during the buyback was 6.29 RMB per share, while the lowest was 5.66 RMB per share [1] - As of the report, the market capitalization of HaiXiang Pharmaceutical is 9.5 billion RMB [1] Group 2 - For the first half of 2025, the revenue composition of HaiXiang Pharmaceutical is as follows: 65.89% from the pharmaceutical manufacturing sector, 33.09% from the dye industry, and 1.02% from other sources [1]